Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS
· Delayed Price · Currency is USD
10.80
-0.20 (-1.82%)
Dec 23, 2024, 4:00 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $17.34 million as of December 26, 2024. Its market cap has increased by 192.68% in one year.
Market Cap
17.34M
Enterprise Value
30.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.80
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 17.34M, a decrease of -98.27%. That is a compound annual growth rate of -65.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 17.34M | 199.17% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 18.23B |
| Telix Pharmaceuticals Limited | 5.14B |
| Elekta AB (publ) | 2.09B |
| Ryman Healthcare Limited | 1.67B |
| Verano Holdings Corp. | 471.76M |
| Vireo Growth Inc. | 126.59M |
| Medexus Pharmaceuticals Inc. | 48.37M |